Skip to main content

Phoenix Financial Ltd.

Position in MRK — Merck & Co., Inc.

CIK 1679543 Givatayim, L3

Position in MRK

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$6,752,803
-$799,604 QoQ
Shares Held
52,551
-16.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#904
of 3,769 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MRK Over Time

Shares Held

Position Value (USD)

Derivatives in MRK

reported options exposure · as of Sep 30, 2024
CallValue
$0
CallShares
0
PutValue
$3,474,936
PutShares
30,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Phoenix Financial Ltd. holds $174,300,668 across 10 Drug Manufacturers - General names. MRK ranks #5 (3.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 MRK
Merck & Co., Inc.
This page
52,551 $6,752,803

All Filings in MRK

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,752,803 52,551
2026-03-31 $7,552,407 62,785
2025-12-31 $6,821,479 64,806
2025-09-30 $3,781,969 45,061
2025-06-30 $3,628,535 45,838
2025-03-31 $8,244,904 91,855
2024-12-31 $10,077,820 101,305
2024-09-30 $3,474,936 30,600
2024-09-30 $18,558,655 163,426
2024-06-30 $14,578,440 117,758
2024-03-31 $14,945,976 113,270
2023-12-31 $10,274,698 94,246
2023-09-30 $7,560,030 73,434
2023-06-30 $6,908,976 59,875
2023-03-31 $4,501,892 42,315
2022-12-31 $2,499,481 22,528
2022-09-30 $1,618,194 18,790
2022-06-30 $1,418,240 15,556
2020-12-31 $29,051,420 355,152
2020-09-30 $33,534,626 404,275
2020-06-30 $31,313,018 404,927
2020-03-31 $17,253,710 224,249